Cargando…
Astragalus membranaceus formula for moderate-high risk idiopathic membranous nephropathy: A meta-analysis
Idiopathic membranous nephropathy (IMN) is a noninflammatory autoimmune glomerulonephropathy. Based on the risk stratification for disease progression, conservative nonimmunosuppressive and immunosuppressive therapy strategies have been recommended. However, there remains challenges. Therefore, nove...
Autores principales: | Wang, Dan, Wang, Lijuan, Zhang, Mingrui, Li, Ping, Zhang, Qinghua, Bao, Kun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981402/ https://www.ncbi.nlm.nih.gov/pubmed/36862887 http://dx.doi.org/10.1097/MD.0000000000032918 |
Ejemplares similares
-
Network pharmacology-based identification of miRNA expression of Astragalus membranaceus in the treatment of diabetic nephropathy
por: Dai, Yaji, et al.
Publicado: (2022) -
Comparison of cyclophosphamide and calcineurin inhibitors for idiopathic membranous nephropathy: A protocol for systematic review and meta-analysis
por: Li, Kang, et al.
Publicado: (2022) -
Idiopathic membranous nephropathy in a patient diagnosed with IgG4-related disease: A case report
por: Ma, XiaoYing, et al.
Publicado: (2020) -
Efficacy and safety of tacrolimus monotherapy versus tacrolimus-corticosteroid combination therapy for idiopathic membranous nephropathy: A meta-analysis
por: Gong, Lifeng, et al.
Publicado: (2021) -
Efficacy and safety of tacrolimus monotherapy versus cyclophosphamide–corticosteroid combination therapy for idiopathic membranous nephropathy: A meta-analysis
por: Gong, Lifeng, et al.
Publicado: (2021)